Summit Capital Management’s Amgen AMGN Stock Holding History

Summit Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$23M	Buy	153,278 +11,337	+8%	+$1.68M	10.39%	2
2015 Q4	$23M	Sell	141,941 -24,700	-15%	-$3.88M	9.32%	2
2015 Q3	$23.1M	Hold	166,641	–	–	11.26%	2
2015 Q2	$25.6M	Hold	166,641	–	–	10.92%	1
2015 Q1	$26.6M	Buy	166,641 +6,672	+4%	+$1.05M	10.73%	1
2014 Q4	$25.5M	Sell	159,969 -7,300	-4%	-$1.14M	9.55%	3
2014 Q3	$23.5M	Sell	167,269 -500	-0.3%	-$65.3K	8.3%	3
2014 Q2	$19.9M	Buy	167,769 +1,995	+1%	+$231K	7.13%	3
2014 Q1	$20.4M	Buy	165,774 +300	+0.2%	+$36.4K	7.23%	3
2013 Q4	$18.9M	Hold	165,474	–	–	7.11%	3
2013 Q3	$18.5M	Hold	165,474	–	–	8.8%	2
2013 Q2	$16.3M	Buy	+165,474	New	+$17.2M	6.95%	5

Other funds holding AMGN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Summit Capital Management's AMGN Position: Q1 2016 in Review

Summit Capital Management increased its Amgen (AMGN) stake by 8% in Q1 2016, buying an estimated $1.68M and bringing the position to 153,278 shares worth $23M. The position accounts for 10.39% of the portfolio, ranked #2.

Summit Capital Management first reported a position in AMGN in Q2 2013 and has held it in 12 quarters since. The position peaked at $26.6M in Q1 2015. 1,435 funds tracked by Wall St. Rank hold AMGN as of Q1 2016.

Summit Capital Management held 153,278 shares of Amgen worth $23M as of Q1 2016.
Summit Capital Management bought 11,337 Amgen shares in Q1 2016, an estimated $1.68M.
Amgen made up 10.39% of Summit Capital Management's portfolio in Q1 2016, its #2 holding.
Summit Capital Management first reported a position in Amgen in Q2 2013 and has held it in 12 quarters since.
Summit Capital Management's Amgen position peaked at $26.6M in Q1 2015.
1,435 funds tracked by Wall St. Rank held Amgen as of Q1 2016.

Based on Summit Capital Management's 13F filing for Q1 2016, filed 11 May 2016.